• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

作者信息

Sánchez-Velázquez A, Bauer-Alonso A, Estrach T, Vega-Díez D, Garcia-Muret P, Haya L, Peñate Y, Acebo E, Fernández de Misa R, Blanes M, Suh-Oh H J, Izu R, Silva-Díaz E, Sarriugarte J, Román-Curto C, Botella-Estrada R, Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sánchez-Caminero P, Calzado L, Pérez-Ferriols A, Pérez A, Domínguez J D, Navedo M, Muniesa C, Combalia A, Arroyo-Andrés J, Descalzo M A, García-Doval I, Ortiz-Romero P L

机构信息

Department of Dermatology, Institute i+12, CIBERONC, Medical School, Hospital Universitario 12 de Octubre, University Complutense, Madrid, Spain.

Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.

出版信息

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e624-e626. doi: 10.1111/jdv.17430. Epub 2021 Jul 2.

DOI:10.1111/jdv.17430
PMID:34062018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8242655/
Abstract
摘要

相似文献

1
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.原发性皮肤淋巴瘤患者有患重症COVID-19的风险。来自西班牙原发性皮肤淋巴瘤登记处的数据。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e624-e626. doi: 10.1111/jdv.17430. Epub 2021 Jul 2.
2
Cutaneous lymphomas and COVID-19: What is known so far?皮肤淋巴瘤与 COVID-19：目前已知情况有哪些？
Dermatol Ther. 2021 Jan;34(1):e14463. doi: 10.1111/dth.14463. Epub 2020 Nov 9.
3
Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic.COVID-19 大流行期间皮肤 T 细胞淋巴瘤的诊断和治疗趋势。
Acta Derm Venereol. 2024 Jul 15;104:adv40505. doi: 10.2340/actadv.v104.40505.
4
The First Year of the AEVD Primary Cutaneous Lymphoma Registry.皮肤原发性蕈样霉菌病登记处的第一年。
Actas Dermosifiliogr (Engl Ed). 2018 Sep;109(7):610-616. doi: 10.1016/j.ad.2018.03.006. Epub 2018 Apr 19.
5
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.国际皮肤淋巴瘤学会大流行分会（ICLYPS）对2019冠状病毒病大流行期间皮肤T细胞淋巴瘤结局的分析：一项回顾性队列研究。
J Am Acad Dermatol. 2023 Apr;88(4):935-937. doi: 10.1016/j.jaad.2022.11.016. Epub 2022 Nov 12.
6
Changing incidence trends of cutaneous B-cell lymphoma.皮肤B细胞淋巴瘤发病率趋势的变化
J Invest Dermatol. 2014 Mar;134(3):840-842. doi: 10.1038/jid.2013.393. Epub 2013 Sep 13.
7
Epidemiological analysis of the Chilean national registry of cutaneous T-cell lymphomas, years 2006-2012.2006 - 2012年智利皮肤T细胞淋巴瘤国家登记处的流行病学分析
Med Clin (Barc). 2020 Mar 27;154(6):236-237. doi: 10.1016/j.medcli.2018.11.011. Epub 2018 Dec 24.
8
Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination.病毒载体新冠疫苗接种后皮肤T细胞淋巴瘤复发
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e91-e93. doi: 10.1111/jdv.17736. Epub 2021 Oct 31.
9
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后原发性皮肤CD30阳性淋巴增殖性疾病复发
Leuk Lymphoma. 2021 Oct;62(10):2554-2555. doi: 10.1080/10428194.2021.1924371. Epub 2021 May 11.
10
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.COVID-19 大流行期间原发性皮肤淋巴瘤患者的管理：欧洲癌症研究与治疗组织皮肤淋巴瘤小组指南。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-1636. doi: 10.1111/jdv.16593. Epub 2020 Jul 7.

引用本文的文献

1
Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.蕈样肉芽肿和塞扎里综合征 COVID-19 的临床结局。
Acta Haematol. 2023;146(6):497-504. doi: 10.1159/000531831. Epub 2023 Jul 29.
2
COVID-19 and non-Hodgkin's lymphoma: A common susceptibility pattern?新型冠状病毒肺炎与非霍奇金淋巴瘤：一种共同的易感性模式？
PLoS One. 2023 Mar 16;18(3):e0277588. doi: 10.1371/journal.pone.0277588. eCollection 2023.
3
Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19.一组皮肤T细胞淋巴瘤合并新型冠状病毒肺炎患者的临床结局
JAAD Int. 2022 Sep;8:52-55. doi: 10.1016/j.jdin.2022.04.008. Epub 2022 May 3.

本文引用的文献

1
Cutaneous lymphomas and COVID-19: What is known so far?皮肤淋巴瘤与 COVID-19：目前已知情况有哪些？
Dermatol Ther. 2021 Jan;34(1):e14463. doi: 10.1111/dth.14463. Epub 2020 Nov 9.
2
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.癌症患者的 COVID-19 严重程度和结局：一项匹配队列研究。
J Clin Oncol. 2020 Nov 20;38(33):3914-3924. doi: 10.1200/JCO.20.01580. Epub 2020 Sep 28.
3
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.COVID-19 大流行期间原发性皮肤淋巴瘤患者的管理：欧洲癌症研究与治疗组织皮肤淋巴瘤小组指南。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-1636. doi: 10.1111/jdv.16593. Epub 2020 Jul 7.
4
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.美国皮肤淋巴瘤协会关于在2019冠状病毒病大流行期间治疗皮肤淋巴瘤的建议。
J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16.
5
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.